Bodybuilding Health+ ED Review 2026: Compounded Tadalafil, Sildenafil & the Editor's Verdict

Yes — Bodybuilding Health+ (BBH+) is a US telehealth platform that connects patients with state-licensed clinicians and partners with state-licensed 503A compounding pharmacies for compounded tadalafil and compounded sildenafil. The platform is operated by CareValidate, an established telehealth operator. BBH+ works within the same US telehealth + 503A regulatory framework used by Hims, Roman, and the broader compounded-medication market. State-licensed pharmacy partners, US-licensed clinicians, US-shipped medication — the three legitimacy markers compounded ED telehealth needs to clear.

BBH+ uses a monthly subscription model bundling clinician consult, medication, and shipping. We don't republish dose-tier pricing in editorial content — current rates are published transparently on bbhealthplus.com after the free intake. Pricing sits in the mid-market for compounded ED telehealth. HSA and FSA funds can typically be applied; commercial insurance does not cover compounded medications.

BBH+ covers most US states. Compounded-medication telehealth access varies state-by-state based on (a) the pharmacy partner's state-board licensure and (b) the prescribing clinician's state license. Enter your state in the BBH+ intake to confirm coverage before completing the questionnaire — this is the standard verification step for every compounded-medication telehealth provider.

These are different programs for different use cases. Hims dispenses FDA-approved brand-name and generic ED medications (sildenafil, tadalafil, Stendra) through a registered pharmacy. BBH+ dispenses compounded tadalafil and compounded sildenafil through 503A pharmacy partners — a different regulatory pathway. Cash-pay patients without insurance often find compounded pricing more accessible; patients with commercial insurance that covers brand-name ED medications usually pay less through the insurance pathway. Both run US-licensed clinician networks. The choice is regulatory pathway and price structure, not legitimacy.

No — compounded tadalafil and compounded sildenafil are not FDA pre-market approved. They are individually compounded preparations made by state-licensed 503A pharmacies under FDA conditions that permit compounding when a patient has a valid prescription. The active ingredients (tadalafil and sildenafil) are the same molecules as the FDA-approved brand-name products. The compounded preparation itself does not go through FDA pre-market approval. This is true of every compounded-medication telehealth provider; it's the regulatory definition of compounding, not a BBH+-specific limitation.

No — compounded medications dispensed through telehealth providers are cash-pay only. Commercial insurance reimbursement requires FDA-approved brand-name or generic medications dispensed through in-network pharmacies. Compounded preparations sit outside that reimbursement framework. HSA and FSA funds can usually be applied to BBH+ charges; check with your benefits administrator. If you have commercial insurance that covers brand-name Cialis or Viagra at a $25/month copay tier, the insurance pathway will be cheaper than any compounded ED program.

After clinician approval (typically 24–72 hours from intake completion), medication ships within 3–7 business days. Refill shipping for established patients is usually 1–3 business days from the auto-refill date. Compounded preparation adds a small lead time vs. off-the-shelf generic dispensing at retail pharmacy. Track shipment status in the BBH+ patient portal.

BBH+ clinicians screen for the standard PDE5-inhibitor contraindications during intake — concurrent nitrate therapy for chest pain, severe cardiovascular disease, recent stroke or heart attack, severe hepatic or renal impairment, certain retinal conditions, and a handful of drug-interaction patterns. If you have any of these, you'll be declined for compounded tadalafil or sildenafil through BBH+ — and through every other telehealth ED provider. That's a clinical-safety decision, not a platform limitation. Talk to a primary-care physician about ED-treatment options that fit your medical history.

FDA-approved brand-name medications (Cialis, Viagra) and their FDA-approved generics (tadalafil, sildenafil sold at retail pharmacy) go through FDA pre-market approval and manufacturer-quality controls. Compounded preparations are made by state-licensed 503A pharmacies under prescriptions tailored to individual patients — the active molecule is the same, but the preparation itself doesn't go through FDA pre-market approval. Compounded pricing is typically more accessible for cash-pay patients without insurance; the trade-off is the different regulatory pathway. This is the same trade-off that applies to compounded GLP-1, compounded testosterone, and other compounded-medication telehealth markets.

Yes — telehealth providers handle prescription transfers routinely. Either provide your current prescription details during BBH+ intake, or restart with a fresh BBH+ clinician evaluation. Most patients who switch are doing so for pricing, faster shipping, or better clinician responsiveness — switching costs in telehealth ED are low. If you're moving between an FDA-approved-brand provider (Hims, Roman) and a compounded provider (BBH+), expect to complete a full new intake since the regulatory pathway is different.